REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Back to transformations
BeforeBefore
AfterAfter
by Remy Patel 82 · 7 days ago

Combined peptide stack for overall wellness. Used BPC-157, Ipamorelin, and GHK-Cu together. Comprehensive progress photos and metrics.

BPC-157IpamorelinGHK-Cu
2026-01-23 → 2026-05-0114 weeks

Comments (2)

Rowan Silva 313·4 days ago

Did you notice any changes in your blood work markers? That would add another layer of useful data.

Rowan Chen 13·4 days ago

Would love to see a 6-month follow-up to see if the gains are maintained long-term.

Sign in to comment.